ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/06/12 | 1,345 | 1,355 | 1,325 | 1,352 | +14 | +1% | 27,000 |
| 2013/06/11 | 1,352 | 1,371 | 1,338 | 1,338 | -29 | -2.1% | 29,000 |
| 2013/06/10 | 1,330 | 1,367 | 1,330 | 1,367 | +38 | +2.9% | 24,000 |
| 2013/06/07 | 1,361 | 1,361 | 1,304 | 1,329 | -62 | -4.5% | 46,000 |
| 2013/06/06 | 1,421 | 1,422 | 1,375 | 1,391 | -31 | -2.2% | 32,000 |
| 2013/06/05 | 1,429 | 1,430 | 1,411 | 1,422 | -7 | -0.5% | 9,000 |
| 2013/06/04 | 1,432 | 1,434 | 1,417 | 1,429 | +27 | +1.9% | 24,000 |
| 2013/06/03 | 1,445 | 1,448 | 1,402 | 1,402 | -19 | -1.3% | 33,000 |
| 2013/05/31 | 1,411 | 1,445 | 1,411 | 1,421 | +14 | +1% | 32,000 |
| 2013/05/30 | 1,417 | 1,434 | 1,404 | 1,407 | -40 | -2.8% | 47,000 |
| 2013/05/29 | 1,470 | 1,470 | 1,430 | 1,447 | +32 | +2.3% | 40,000 |
| 2013/05/28 | 1,436 | 1,436 | 1,410 | 1,415 | -1 | -0.1% | 29,000 |
| 2013/05/27 | 1,468 | 1,468 | 1,400 | 1,416 | -82 | -5.5% | 48,000 |
| 2013/05/24 | 1,450 | 1,514 | 1,422 | 1,498 | +45 | +3.1% | 54,000 |
| 2013/05/23 | 1,540 | 1,540 | 1,451 | 1,453 | -89 | -5.8% | 49,000 |
| 2013/05/22 | 1,557 | 1,560 | 1,540 | 1,542 | -18 | -1.2% | 43,000 |
| 2013/05/21 | 1,568 | 1,568 | 1,539 | 1,560 | ±0 | ±0% | 64,000 |
| 2013/05/20 | 1,570 | 1,570 | 1,560 | 1,560 | -2 | -0.1% | 45,000 |
| 2013/05/17 | 1,575 | 1,576 | 1,553 | 1,562 | +15 | +1% | 118,000 |
| 2013/05/16 | 1,500 | 1,576 | 1,500 | 1,547 | +43 | +2.9% | 91,000 |
| 2013/05/15 | 1,499 | 1,508 | 1,496 | 1,504 | -4 | -0.3% | 26,000 |
| 2013/05/14 | 1,509 | 1,516 | 1,508 | 1,508 | -1 | -0.1% | 14,000 |
| 2013/05/13 | 1,518 | 1,520 | 1,500 | 1,509 | -2 | -0.1% | 22,000 |
| 2013/05/10 | 1,524 | 1,524 | 1,509 | 1,511 | -1 | -0.1% | 14,000 |
| 2013/05/09 | 1,507 | 1,532 | 1,507 | 1,512 | +5 | +0.3% | 20,000 |
| 2013/05/08 | 1,505 | 1,520 | 1,505 | 1,507 | -5 | -0.3% | 20,000 |
| 2013/05/07 | 1,518 | 1,519 | 1,505 | 1,512 | +5 | +0.3% | 18,000 |
| 2013/05/02 | 1,483 | 1,507 | 1,483 | 1,507 | +4 | +0.3% | 12,000 |
| 2013/05/01 | 1,514 | 1,514 | 1,502 | 1,503 | +4 | +0.3% | 10,000 |
| 2013/04/30 | 1,510 | 1,520 | 1,494 | 1,499 | -14 | -0.9% | 37,000 |
| 2013/04/26 | 1,508 | 1,515 | 1,502 | 1,513 | -6 | -0.4% | 22,000 |
| 2013/04/25 | 1,520 | 1,521 | 1,515 | 1,519 | +3 | +0.2% | 31,000 |
| 2013/04/24 | 1,519 | 1,519 | 1,511 | 1,516 | -2 | -0.1% | 19,000 |
| 2013/04/23 | 1,517 | 1,518 | 1,510 | 1,518 | +1 | +0.1% | 17,000 |
| 2013/04/22 | 1,507 | 1,518 | 1,504 | 1,517 | +53 | +3.6% | 26,000 |
| 2013/04/19 | 1,476 | 1,478 | 1,458 | 1,464 | +9 | +0.6% | 20,000 |
| 2013/04/18 | 1,483 | 1,483 | 1,455 | 1,455 | -18 | -1.2% | 18,000 |
| 2013/04/17 | 1,466 | 1,490 | 1,466 | 1,473 | +7 | +0.5% | 22,000 |
| 2013/04/16 | 1,486 | 1,495 | 1,465 | 1,466 | -22 | -1.5% | 29,000 |
| 2013/04/15 | 1,500 | 1,500 | 1,488 | 1,488 | -18 | -1.2% | 7,000 |
| 2013/04/12 | 1,510 | 1,512 | 1,500 | 1,506 | -1 | -0.1% | 18,000 |
| 2013/04/11 | 1,510 | 1,512 | 1,507 | 1,507 | +1 | +0.1% | 13,000 |
| 2013/04/10 | 1,510 | 1,510 | 1,497 | 1,506 | -6 | -0.4% | 10,000 |
| 2013/04/09 | 1,507 | 1,515 | 1,506 | 1,512 | +6 | +0.4% | 22,000 |
| 2013/04/08 | 1,501 | 1,515 | 1,482 | 1,506 | -5 | -0.3% | 39,000 |
| 2013/04/05 | 1,490 | 1,515 | 1,490 | 1,511 | +29 | +2% | 47,000 |
| 2013/04/04 | 1,464 | 1,482 | 1,445 | 1,482 | +30 | +2.1% | 22,000 |
| 2013/04/03 | 1,415 | 1,454 | 1,415 | 1,452 | +38 | +2.7% | 14,000 |
| 2013/04/02 | 1,457 | 1,457 | 1,413 | 1,414 | -44 | -3% | 27,000 |
| 2013/04/01 | 1,482 | 1,482 | 1,432 | 1,458 | +6 | +0.4% | 19,000 |
2801～
2850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
